Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2 (KRTCAP2) is a protein component of the oligosaccharyltransferase (OST) complex responsible for catalyzing the initial transfer of a glycan from dolichol-pyrophosphate to an asparagine residue in nascent polypeptide chains during co-translational protein N-glycosylation in the endoplasmic reticulum. KRTCAP2 acts as an adapter, anchoring the OST-A complex to the Sec61 complex at the translocon, and is essential for normal glycosylation of proteins[1][9][8]. There is no direct evidence that it is a drug target, nor are there known interacting drugs or safety concerns related to its modulation. Variants in KRTCAP2 are associated with rare autosomal recessive diseases, including a granulomatous disorder and intellectual developmental delay[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2 (KRTCAP2).